Sai Life Sciences Limited has informed the Exchange regarding revised Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Allotment of equity shares under Employees Stock Option Plan 2008 ( ESOP 2008 ) and Management ESOP Plan 2018 ( MESOP 2018 ).
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has allotted a total of 1,39,007 equity shares (Re. 1 face value) to employees upon exercise of stock options — 29,007 shares under the ESOP 2008 plan and 1,10,000 shares under the MESOP 2018 plan. The Board approved the allotment at its meeting on 22 February 2026, and the company received about Rs. 1.22 crore from this exercise. This is a revised filing — the earlier intimation dated 23 February 2026 had inadvertently omitted 10,000 ESOP shares, which have now been included. After this allotment, the total issued share count stands at 21,17,68,134 shares. Exercise prices were Rs. 188.90 per share for ESOP 2008 and Rs. 23.30 and Rs. 127.30 per share for MESOP 2018. There is no lock-in on the newly issued shares.
This is a routine employee stock option allotment resulting in very minor dilution (roughly 0.07% increase in share count). No material impact on share price is expected, though it signals that employees are exercising vested options, which is a normal operational event.